Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients

The DecisionDx-Melanoma test provides prognostic information for patients with cutaneous melanoma (CM). Using formalin-fixed paraffin-embedded primary tumor tissue, the RT-PCR-based test classifies patients into a low- (Class 1) or high-risk (Class 2) category for recurrence based on expression of 3...

全面介绍

Saved in:
书目详细资料
Main Authors: Robert W. Cook, Brooke Middlebrook, Jeff Wilkinson, Kyle R. Covington, Kristen M. Oelschlager, Federico A. Monzon, John F. Stone
格式: Artigo
语言:英语
出版: 2018
在线阅读:https://doi.org/10.1186/s13000-018-0690-3
https://diagnosticpathology.biomedcentral.com/track/pdf/10.1186/s13000-018-0690-3
标签: 添加标签
没有标签, 成为第一个标记此记录!